Your browser doesn't support javascript.
loading
Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents.
Coombes, Naomi S; Bewley, Kevin R; Le Duff, Yann; Hurley, Matthew; Smith, Lauren J; Weldon, Thomas M; Osman, Karen; Pullan, Steven; Berry, Neil; Hallis, Bassam; Charlton, Sue; Hall, Yper; Funnell, Simon G P.
Afiliación
  • Coombes NS; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.
  • Bewley KR; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.
  • Le Duff Y; Division of Infectious Disease Diagnostics, National Institute for Biological Standards, Medicines and Healthcare Products Regulatory Agency, Potters Bar EN6 3QG, UK.
  • Hurley M; Division of Infectious Disease Diagnostics, National Institute for Biological Standards, Medicines and Healthcare Products Regulatory Agency, Potters Bar EN6 3QG, UK.
  • Smith LJ; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.
  • Weldon TM; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.
  • Osman K; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.
  • Pullan S; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.
  • Berry N; Division of Infectious Disease Diagnostics, National Institute for Biological Standards, Medicines and Healthcare Products Regulatory Agency, Potters Bar EN6 3QG, UK.
  • Hallis B; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.
  • Charlton S; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.
  • Hall Y; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.
  • Funnell SGP; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.
Viruses ; 15(3)2023 02 25.
Article en En | MEDLINE | ID: mdl-36992342
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Viruses Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Viruses Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido